Alexar Therapeutics Inc.

Creating an atopic dermatitis treatment from an LXR agonist

 
• By Deborah Erickson
  
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Archive

More from Scrip